Huan The Tran

Hue University · Faculty of Pharmacy

Alzheimer’s disease (AD) is a neurodegenerative illness that affects the brain and is linked to cognitive decline, memory problems, and behavioral changes. It is highly prevalent in the elderly, with a constantly growing number of new cases worldwide. In affluent nations with aging populations, AD has been a major source of economic and social prob...

Background: Pancreatic lipase is one of the safest targets of anti-obesity drugs. To date, orlistat is the only pancreatic lipase inhibitor approved for the long-term treatment of obesity. Therefore, there is an elevated need to find new drugs for this disease. Determining the factors affecting the test to evaluate pancreatic lipase inhibitory acti...

Abstract: Background: Over the past 15 years, thrombosis has been one of the most common causes of death. Current antiplatelet therapies could limit the morbidity and mortality from thromboembolic diseases, but they still have side effects such as uncontrolled bleeding, and patients’ intolerance. Therefore, finding new antiplatelet agents is an imp...

Background: Over the past 15 years, thrombosis has been one of the most common causes of death. Current antiplatelet therapies could limit the morbidity and mortality from thromboembolic diseases, but they still have side effects such as uncontrolled bleeding, and patients’ intolerance. Therefore, finding new antiplatelet agents is an important goa...

Alzheimer’s disease (AD) is an irreversible neurodegenerative disease that affects many older people adversely. AD has been putting a huge socioeconomic burden on the healthcare systems of many developed countries with aging populations. The need for new therapies that can halt or reverse the progression of the disease is now extremely great. A res...

In study on acetylcholinesterase inhibitors for the treatment of Alzheimer's disease, eight derivatives of baicalein were semi-synthesized by etherification. The synthesized derivatives were tested for inhibitory activity on acetylcholinesterase in vitro by Ellman's method in comparison with baicalein material itself. Of these, three derivative dem...

Acetylcholinesterase (AChE) and β-secretase (BACE-1) have become attractive therapeutic targets for Alzheimer's disease (AD). Flavones are flavonoid derivatives with various bioactive effects, including AChE and BACE-1 inhibition. In the present work, a series of 14 flavone derivatives was synthesized in relatively high yields (35-85%). Six of the...

Acetylcholinesterase (AChE) and beta-secretase (BACE-1) are two attractive targets in the discovery of novel substances that could control multiple aspects of Alzheimer’s disease (AD). Chalcones are the flavonoid derivatives with diverse bioactivities, including AChE and BACE-1 inhibition. In this study, a series of N-substituted-4-phenothiazine-ch...

Acetylcholinesterase (AChE) and beta-secretase (BACE-1) are the two crucial enzymes involved in the pathology of Alzheimer’s disease. The former is responsible for many defects in cholinergic signaling pathway and the latter is the primary enzyme in the biosynthesis of beta-amyloid as the main component of the amyloid plaques. These both abnormalit...

Baicalein is a potential flavonoid for acetylcholinesterase inhibitor research to treat Alzheimer's disease. Six baicalein derivatives have been semi-synthesized via esterification and amino alkylation reactions. The in vitro acetylcholinesterase inhibitory activity of these derivatives was evaluated with the Ellman method, and certain improvement...